Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/109602
Título: | Effect of Maraviroc intensification on HIV-1-specific T cell immunity in recently HIV-1-infected individuals |
---|---|
Autor/a: | Kawana-Tachikawa, Ai; Llibre, Josep M.; Bravo, Isabel; Escrig, Roser; Mothe, Beatriz; Puig, Jordi; Puertas, Maria C.; Martínez Picado, Francisco Javier; Blanco, Julià; Manzardo, Christian; Miró Meda, José M.; Iwamoto, Aikichi; Pozniak, Anton L.; Gatell, José M.; Clotet i Sala, Bonaventura; Brander, Christian |
Otros autores: | Universitat de Barcelona |
Abstract: | BACKGROUND: The effect of maraviroc on the maintenance and the function of HIV-1-specific T cell responses remains unknown. METHODS: Subjects recently infected with HIV-1 were randomized to receive anti-retroviral treatment with or without maraviroc intensification for 48 weeks, and were monitored up to week 60. PBMC and in vitro-expanded T cells were tested for responses to the entire HIV proteome by ELISpot analyses. Intracellular cytokine staining assays were conducted to monitor the (poly)-functionality of HIV-1-specific T cells. Analyses were performed at baseline and week 24 after treatment start, and at week 60 (3 months after maraviroc discontinuation). RESULTS: Maraviroc intensification was associated with a slower decay of virus-specific T cell responses over time compared to the non-intensified regimen in both direct ex-vivo as well as in in-vitro expanded cells. The effector function profiles of virus-specific CD8⁺ T cells were indistinguishable between the two arms and did not change over time between the groups. CONCLUSIONS: Maraviroc did not negatively impact any of the measured parameters, but was rather associated with a prolonged maintenance of HIV-1-specific T cell responses. Maraviroc, in addition to its original effect as viral entry inhibitor, may provide an additional benefit on the maintenance of virus-specific T cells which may be especially important for future viral eradication strategies. |
Materia(s): | -Cèl·lules T -VIH (Virus) -Antiretrovirals -Resposta immunitària -Genètica molecular -T cells -HIV (Viruses) -Antiretroviral agents -Immune response -Molecular genetics |
Derechos: | cc-by (c) Kawana-Tachikawa, Ai et al., 2014
http://creativecommons.org/licenses/by/3.0/es |
Tipo de documento: | Artículo Artículo - Versión publicada |
Editor: | Public Library of Science (PLoS) |
Compartir: |